Shopping Cart 0
Cart Subtotal
AED 0

Middle East & Africa Wound Care Biologics Market_Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 9175

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 11744
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Middle East & Africa wound care biologics market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases, rising number of geriatric population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for Middle East & Africa wound care biologics market are listed below:

MiMedx

WRIGHT MEDICAL GROUP N.V

Smith and Nephew

INTEGRA LIFE SCIENCES CORPORATION

Molnlycke Health Care AB

ConvaTec Inc

The Middle East & Africa wound care biologics market is segmented into:

Product Type

Wound Type

End User

On the basis of product type segment the Middle East & Africa wound care biologics market is segmented into synthetic skin grafts segment, growth factors segment, allografts segment, xenografts segment. In 2018, synthetic skin grafts segment is expected to dominate the Middle East & Africa wound care biologics market with highest market shares. However, allografts segment is expected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF) segment, platelet rich plasma (PRP) segment, epidermal growth factor (EGF) segment and basic fibroblast growth factor (BFGF) segment, granulocyte colony stimulating factor (G-CSF) segment, talactoferrin alfa, thrombin peptide (TP508) segment, keratinocyte growth factor (KGF) segment.

On the basis of wound type the Middle East & Africa wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segment is expected to dominate the Middle East & Africa wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.

On the basis of end user Middle East & Africa wound care biologics market is segmented into hospitals, wound care centres and ambulatory centres, clinics, community healthcare centers. In 2018, hospitals are expected to dominate the Middle East & Africa wound care biologics market with the highest CAGR in the forecast period 2018 to 2025.

Based on geography, the market is segmented into following countries:

South Africa

Rest of Middle East & Africa

The report covers the present scenario and the growth prospects of the Middle East & Africa wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

READ MORE

Table Of Content

Scope

Table Of Contents

1 Introduction 30

1.1 Objectives Of The Study 30

1.2 Market Definition 30

1.3 Overview Of Middle East-And Africa Wound Care Biologics Market 30

1.4 Currency And Pricing 31

1.5 Limitation 31

1.6 Markets Covered 32

2 Market Segmentation 34

2.1 Markets Covered 34

2.2 Geographic Scope 35

2.3 Years Considered For The Study 36

2.4 Currency And Pricing 36

2.5 Research Methodology 37

2.6 Primary Interviews With Key Opinion Leaders 40

2.1 Dbmr Market Position Grid 41

2.2 Dbmr Market Challenge Matrix 42

2.3 Secondary Sources 43

2.4 Assumptions 43

3 Market Overview 44

3.1 Drivers 46

3.1.1 Increasing Cases Of Diabetic Foot Ulcers 46

3.1.2 Increasing Incidences Of Burn Cases 46

3.1.3 Rising Number Of Geriatric Population 47

3.1.4 Innovation In Wound Care Biologics 48

3.1.5 New Product Launches 50

3.2 Restrains 50

3.2.1 High Cost Of Wound Treatment And Wound Care Biologics 50

3.2.2 Risk Of Skin Substitue Failure 51

3.3 Opportunities 52

3.3.1 3D Skin Printing 52

3.3.2 Awareness Programs 53

3.4 Challenges 54

3.4.1 Lack Of Wound Management Services 54

4 Executive Summary 55

5 Premium Insights 58

6 Middle East-And Africa Wound Care Biologics Market, By Product Type 63

6.1 Overview 64

6.2 Synthetic Skin Grafts 66

6.3 Growth Factors 67

6.3.1 Platelet Derived Growth Factor (Pdgf) 70

6.3.2 Platelet Rich Plasma (Prp) 70

6.3.3 Epidermal Growth Factors (Egf) 70

6.3.4 Basic Fibroblast Growth Factors (Bfgf) 71

6.3.5 Granulocyte Colony Stimulating Factor (G-Csf) 71

6.3.6 Talactoferrin Alfa 71

6.3.7 Thrombin Peptide 72

6.3.8 Keratinocy Growth Factor (Kgf) 72

6.4 Allografts 73

6.5 Xenografts 74

7 Middle East-And Africa Wound Care Biologics Market, By Wound Type 76

7.1 Overview 77

7.2 Wounds 78

7.2.1 Surgical Wound 80

7.2.1.1 Skin Surgery 81

7.2.1.1.1 Wound Closure 82

7.2.1.1.2 Skin Biopsy 82

7.2.1.1.3 Skin Flap 82

7.2.1.1.4 Skin Graft 82

7.2.1.1.5 Others 82

7.2.1.2 Cosmetic Procedure 83

7.2.1.2.1 Brest Enhancement 84

7.2.1.2.2 Facial Contouring 85

7.2.1.2.3 Facial Rejuvenation: 85

7.2.1.2.4 Body Contouring 85

7.2.1.2.5 Skin Rejuvenation 85

7.2.1.2.6 Others 86

7.2.1.3 Gynecologic Procedures 86

7.2.1.3.1 Pubovaginalis Sling 86

7.2.1.3.2 Pelvic Floor Reconstruction 87

7.2.1.3.3 Rectocele Repair Surgery 87

7.2.1.3.4 Others 87

7.2.1.4 Gastrointestinal Procedure 87

7.2.1.4.1 General Gastrointestinal Surgery 88

7.2.1.4.2 Hernia 89

7.2.1.4.3 Others 89

7.2.2 Acute Wounds 90

7.2.3 Chronic Wounds 90

7.2.4 Traumatic Wounds 91

7.3 Burns 91

7.3.1 Ulcers 92

7.3.2 Diabetic Ulcers 94

7.3.3 Pressure Ulcer 94

7.3.4 Venous Ulcer 95

7.3.5 Others 95

8 Middle East-And Africa Wound Care Biologics Market, By End User 96

8.1 Overview 97

8.2 Hospitals 99

8.3 Wound Care Centers 100

8.4 Ambulatory Surgical Centers 101

8.5 Clinics 103

8.6 Community Healthcare Center 104

9 Middle East-And Africa Wound Care Biologics Market: Geography 105

9.1 Middle East & Africa 105

9.1.1 South Africa 116

9.1.2 Rest Of Middle East & Africa 123

10 Middle East-And Africa Wound Care Biologics Market, Company Landscape 124

10.1 Company Share Analysis: Middle East-And Africa 124

11 Company Profile 125

11.1 Mimedx. 125

11.1.1 Company Overview 125

11.1.2 Revenue Analysis: 125

11.1.3 Company Share Analysis: 126

11.1.4 Product Portfolio 126

11.1.5 Recent Developments 127

11.2 Organogenesis Inc 128

11.2.1 Company Overview 128

11.2.2 Geographic Presence 128

11.2.3 Company Share Analysis: 129

11.2.4 Product Portfolio 129

11.2.5 Recent Developments 130

11.3 Integra Lifesciences 131

11.3.1 Company Overview 131

11.3.2 Revenue Analysis 131

11.3.3 Company Share Analysis: 132

11.3.4 Product Portfolio 132

11.3.5 Recent Developments 133

11.4 Convatec Inc. 134

11.4.1 Company Overview 134

11.4.2 Revenue Analysis 134

11.4.3 Company Share Analysis: 135

11.4.4 Product Portfolio : 135

11.4.5 Recent Developments 135

11.5 Acell Inc. 136

11.5.1 Company Overview 136

11.5.2 Product Portfolio 136

11.5.3 Recent Developments 137

11.6 Allosource 138

11.6.1 Company Overview 138

11.6.2 Product Portfolio 138

11.6.3 Recent Developments 139

11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc) 140

11.7.1 Company Overview 140

11.7.2 Product Portfolio 140

11.7.3 Recent Developments 140

11.8 Amnio Technology, Llc 141

11.8.1 Company Overview 141

11.8.2 Product Portfolio 141

11.8.3 Recent Developments 142

11.9 Amniox Medical, Inc. 143

11.9.1 Company Overview 143

11.9.2 Product Portfolio 143

11.9.3 Recent Developments 144

11.10 Anika Therapeutics, Inc. 145

11.10.1 Company Overview 145

11.10.2 Revenue Analysis 145

11.10.3 Product Portfolio 146

11.10.4 Recent Developments 146

11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.) 147

11.11.1 Company Overview 147

11.11.2 Geographicpresence 147

11.11.3 Product Portfolio 148

11.11.4 Recent Developments 148

11.12 Kerecis 149

11.12.1 Company Overview 149

11.12.2 Geographical Presence 149

11.12.3 Product Portfolio 150

11.12.4 Recent Developments 150

11.13 Marine Polymer Technologies, Inc 151

11.13.1 Company Overview 151

11.13.2 Product Portfolio 151

11.13.3 Recent Developments 151

11.14 Molnlycke Health Care Ab 152

11.14.1 Company Overview 152

11.14.2 Revenue Analysis 152

11.14.3 Product Portfolio 153

11.14.4 Recent Developments 153

11.15 Osiris Therapeutics, Inc. 154

11.15.1 Company Overview 154

11.15.2 Revenue Analysis 154

11.15.3 Product Portfolio 155

11.15.4 Recent Developments 155

11.16 Skye Biologics Inc. 156

11.16.1 Company Overview 156

11.16.2 Product Portfolio : 156

11.16.3 Recent Development: 157

11.17 Smith And Nephew 158

11.17.1 Company Overview 158

11.17.2 Revenue Analysis 158

11.17.3 Product Portfolio 159

11.17.4 Recent Developments 159

11.18 Solsys Medical. 160

11.18.1 Company Overview 160

11.18.2 Product Portfolio 161

11.18.3 Recent Developments 161

11.19 Vericel Corporation. 162

11.19.1 Company Overview 162

11.19.2 1.1.2 Revenue Analysis 162

11.19.3 Product Portfolio 163

11.19.4 Recent Developments 163

11.20 Wright Medical Group N.V 164

11.20.1 Company Overview 164

11.20.2 1.1.2 Revenue Analysis 164

11.20.3 Product Portfolio 165

11.20.4 Recent Developments 166

12 Related Reports 167


List Of Figure

List Of Figures

Figure 1 Middle East-And Africa Wound Care Biologics Market: Segmentation 19

Figure 2 Middle East-And Africa Wound Care Biologics Market: Data Triangulation 22

Figure 3 Middle East-And Africa Wound Care Biologics Market: Research Snapshot 23

Figure 4 Middle East-And Africa Wound Care Biologics Market: Bottom Up Approach 24

Figure 5 Middle East-And Africa Wound Care Biologics Market: Top Down Approach 24

Figure 6 Middle East-And Africa Wound Care Biologics Market: Interview Demographics 25

Figure 1 Middle East-And Africa Wound Care Biologics Market: Dbmr Market Position Grid 26

Figure 2 Middle East-And Africa Wound Care Biologics Market: The Market Challenge Matrix 27

Figure 3 Drivers, Restraints, Opportunities And Challenges Of Middle East-And Africa Wound Care Biologics Market 30

Figure 4 Aging Population In Different Countries (2014, 2017 & 2020) 33

Figure 5 Middle East-And Africa Wound Care Biologics Market: Segmentation 42

Figure 6 Increasing Prevelance Of Diabetic Foot Ulcers And Increasing Incidences Of Burn Cases Are Expected To Drive The Market For Middle East-And Africa Wound Care Biologics In The Forecast Period 2018 To 2025 43

Figure 7 Synthetic Skin Grafts In Middle East-And Africa Wound Care Biologics Is Expected To Account For The Largest Share Of The Middle East-And Africa Wound Care Biologics Market In 2018 & 2025 44

Figure 8 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For Middle East-And Africa Wound Care Biologics Market In The Forecast Period From 2018 To 2025 45

Figure 9 Worldwide Prevalence Of Various Wound Types, 2011 46

Figure 10 Cases Of Burn Injuries, (2009-2012) 46

Figure 11 Prevalence Of Pressure Ulcers In Few Countries 47

Figure 12 Number Of Surgical Procedures And Surgical Site Infections 47

Figure 13 Middle East-And Africa Wound Care Biologics Market: By Product Type, 2017 49

Figure 14 Middle East-And Africa Wound Care Biologics Market: By Wound Type, 2017 62

Figure 15 Middle East-And Africa Wound Care Biologics Market: By End User, Snapshot 2017 82

Figure 16 Middle East & Africa Wound Care Biologics Market: Snapshot (2017) 90

Figure 17 Middle East & Africa Wound Care Biologics Market: By Country (2017) 91

Figure 18 Middle East & Africa Wound Care Biologics Market: By Country (2018 & 2025) 91

Figure 19 Middle East & Africa Wound Care Biologics Market, By Country (2017 & 2025) 92

Figure 20 Middle East & Africa Wound Care Biologics Market, By Product Type (2018 -2025) 93

Figure 21 Middle East-And Africa Wound Care Biologics Market: Company Share 2017 (%) 109


List Of Table

List Of Tables

Table 1 Middle East-And Africa Wound Care Biologics Market, By Product Type, 2016- 2025 (Usd Million) 51

Table 2 Middle East-And Africa Synthetic Skin Grafts In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 52

Table 3 Middle East-And Africa Growth Factors In Wound Care Biologics Market, By Product Type, 2016- 2025 (Usd Million) 54

Table 4 Middle East-And Africa Growth Factors In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 55

Table 5 Middle East-And Africa Allografts In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 59

Table 6 Middle East-And Africa Xenografts In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 61

Table 7 Middle East-And Africa Wound Care Biologics Market, By Wound Type, 2015- 2025 (Usd Million) 64

Table 8 Middle East-And Africa Wounds In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 65

Table 9 Middle East-And Africa Wounds In Wound Care Biologics Market, By Wound Type, 2016- 2025 (Usd Million) 65

Table 10 Middle East-And Africa Surgical Wound In Wound Care Biologics Market, 2016-2025 (Usd Million) 66

Table 11 Middle East-And Africa Skin Surgery In Wound Care Biologics Market, 2016-2025 (Usd Million) 67

Table 12 Number Of Cosmetic Surgery, 2016 & 2017 69

Table 13 Middle East-And Africa Cosmetic Surgery In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million) 70

Table 14 Middle East-And Africa Gynecologic Procedures In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million) 72

Table 15 Middle East-And Africa Gastrointestinal Procedures In Wound Care Biologics Market, By Wound Type 2018-2025 (Usd Million) 74

Table 16 Middle East-And Africa Burns In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 78

Table 17 Middle East-And Africa Ulcers In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 79

Table 18 Middle East-And Africa Ulcers In Wound Care Biologics Market, By Wound Type 2016-2025 (Usd Million) 79

Table 19 Middle East-And Africa Wound Care Biologics Market, By End User, 2016-2025 (Usd Million) 84

Table 20 Middle East-And Africa Hospitals In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 85

Table 21 Middle East-And Africa Wound Care Center In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 86

Table 22 Statistics For Ambulatory Surgical Center. U.S. 87

Table 23 Middle East-And Africa Ambulatory Surgical Centers In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 88

Table 24 Middle East-And Africa Clinics In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 89

Table 25 Middle East-And Africa Community Healthcare Center In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 90

Table 26 Middle East & Africa Wound Care Biologics Market, By Country, Usd Million (2016-2025) 95

Table 27 Middle East & Africa Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 95

Table 28 Middle East & Africa Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 96

Table 29 Middle East & Africa Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 96

Table 30 Middle East & Africa Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 97

Table 31 Middle East & Africa Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 97

Table 32 Middle East & Africa Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 98

Table 33 Middle East & Africa Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 99

Table 34 Middle East & Africa Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 99

Table 35 Middle East & Africa Gastrointestinal Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 100

Table 36 Middle East & Africa Gastrointestinal Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 100

Table 37 Middle East & Africa Wound Care Biologics, By End User, 2016-2025, (Usd Million) 101

Table 38 South Africa Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 102

Table 39 South Africa Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 103

Table 40 South Africa Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 103

Table 41 South Africa Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 104

Table 42 South Africa Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 104

Table 43 South Africa Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 105

Table 44 South Africa Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 106

Table 45 South Africa Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 106

Table 46 South Africa Gastrointestinal Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 107

Table 47 South Africa Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 107

Table 48 South Africa Wound Care Biologics, By End User, 2016-2025, (Usd Million) 108

Table 49 Rest Of Middle East & Africa Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 109

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

MiMedx

Organogenesis Inc.

Integra LifeSciences

ConvaTec Inc.

Smith and Nephew

INTEGRA LIFE SCIENCES CORPORATION

Molnlycke Health Care AB